Efinaconazole
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 252 publications
Telemedicine visits for new onychomycosis diagnoses result in fewer antifungal prescriptions than in-person care: A retrospective cohort study.
Journal: JAAD international
Published: January 21, 2026
Topical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Analysis in White, Black, and Asian Participants.
Journal: Journal of drugs in dermatology : JDD
Published: January 06, 2026
Treating Onychomycosis with Efinaconazole: Considerations for Diverse Patient Groups.
Journal: Journal of fungi (Basel, Switzerland)
Published: October 21, 2025
Enhanced Efinaconazole Permeation and Activity Against Trichophyton rubrum and Trichophyton mentagrophytes with a Self-Nanoemulsifying Drug Delivery System.
Journal: Pharmaceutics
Published: August 28, 2025
Onychomycosis in Diabetics: A Common Infection with Potentially Serious Complications.
Journal: Life (Basel, Switzerland)
Published: July 09, 2025
Emerging Antifungal-Resistant Onychomycosis in a Dermatology Clinic in Kumamoto, Japan.
Journal: Medical mycology journal
Published: June 01, 2025
Antifungal Agents' Trends of Utilization, Spending, and Prices in the US Medicaid Programs: 2009-2023.
Journal: Antibiotics (Basel, Switzerland)
Published: April 01, 2025
Efficacy and Safety of Efinaconazole 10% Topical Solution for Treatment of Onychomycosis in Older Adults: A Post Hoc Analysis of Two Phase 3 Randomised Trials.
Journal: Mycoses
Published: March 07, 2025
Terbinafine-Resistant Dermatophytes Isolated in Japan.
Journal: Medical mycology journal
Published: March 02, 2025
Safety and Efficacy of a 48-Month Efinaconazole 10% Solution Treatment/Maintenance Regimen: 24-Month Daily Use Followed by 24-Month Intermittent Use.
Journal: Infectious disease reports
Published: December 06, 2024
Last Updated: 04/28/2026